XGN · Exagen Inc.
$6.66
+0.08 (+1.22%)
At close · Aug 14
Market Cap
$161.34M
Shares
24.23M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2022-09-15 | 2023-11-17 | $50,000,000 | — | — | 10-Q , filed 2025-07-29 |
Key facts
CIK
1274737
CUSIP
30068X103
13F (30d)
57 filings
57 filers
Visit website
Investor relations